Saturday, November 30th, 2024

LHN Limited Announces Generous Final and Special Dividends for FY2024 with Scrip Option








LHN Limited Announces Final and Special Dividends for 2024; Potential Impact on Share Price

LHN Limited Announces Final and Special Dividends for 2024; Potential Impact on Share Price

LHN Limited, a company incorporated in Singapore, has announced its intention to distribute a tax-exempt final dividend of S\$0.01 (equivalent to HK\$0.0578) per share and a special dividend of the same amount for the financial year ending 30 September 2024. Both dividend payments are subject to the approval of shareholders at the annual general meeting (AGM) scheduled for 24 January 2025.

Upon receiving shareholder approval, the final dividend will be disbursed on 21 February 2025 to shareholders listed on the register by the close of business on 7 February 2025. The special dividend is slated for payment on 30 May 2025, with eligibility determined based on the register as of 10 April 2025.

The Company offers shareholders an option to receive the special dividend as scrip shares, cash, or a combination of both through the Scrip Dividend Scheme. This scheme, however, is contingent on securing necessary approvals from both the AGM and relevant stock exchanges.

Shareholders in Singapore and Hong Kong should take note of registration deadlines to ensure eligibility for the dividends. Singapore shareholders must ensure their transfers are completed by 7 February 2025 for the final dividend, and by 10 April 2025 for the special dividend. Hong Kong shareholders, meanwhile, need to lodge their transfers with the Company’s registrar by the same respective dates.

This announcement carries potential implications for LHN Limited’s share value, as dividend distributions and shareholder options may affect market perceptions and trading activity. Investors should monitor further developments closely, especially regarding approvals for the Scrip Dividend Scheme.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investors are advised to conduct their own research or consult a financial advisor before making investment decisions.




View LHN Historical chart here



Hyphens Pharma Reports Mixed Q3 Results: Revenue Up, Profit Down

Hyphens Pharma Reports Strong Growth with 22.1% Revenue Increase in 9M2024 Hyphens Pharma Reports Strong Growth with 22.1% Revenue Increase in 9M2024 Hyphens Pharma International Limited has released their quarterly business update for the...

Civmec Wins Major Shiploader Contract: A$90-100M Project Boost Amid FY25 Outlook Concerns

Major Project Win and Strong Outlook: Civmec’s \$100M Shiploader Contract Major Project Win and Strong Outlook: Civmec’s \$100M Shiploader Contract Civmec Limited (ASX:CVL, SGX:P9D) has announced a significant milestone in their business activities with...

IREIT Global’s Bold Move: Betting on Berlin Campus Transformation Amid European Real Estate Uncertainty

IREIT Global Reports Stable 3Q2024 Performance Despite Challenges in Spanish Portfolio IREIT Global Reports Stable 3Q2024 Performance Despite Challenges in Spanish Portfolio IREIT Global has released its 3Q2024 business update, showcasing a stable performance...